Rhythm Biosciences Limited (FRA:0RY)
0.0500
-0.0005 (-0.99%)
Last updated: Oct 23, 2025, 3:29 PM CET
Rhythm Biosciences Revenue
In the fiscal year ending June 30, 2025, Rhythm Biosciences had annual revenue of 3.19M AUD with 88.85% growth. Rhythm Biosciences had revenue of 25.63K in the half year ending June 30, 2025, a decrease of -93.16%.
Revenue
3.19M AUD
Revenue Growth
+88.85%
P/S Ratio
9.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.02M EUR
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.19M | 1.50M | 88.85% |
| Jun 30, 2024 | 1.69M | -1.41M | -45.41% |
| Jun 30, 2023 | 3.10M | 668.44K | 27.54% |
| Jun 30, 2022 | 2.43M | 1.32M | 118.98% |
| Jun 30, 2021 | 1.11M | 1.01M | 1,008.51% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 139.36B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Aktiengesellschaft | 78.30B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Siemens Energy AG | 38.39B |
| SAP SE | 36.49B |
| Deutsche Bank Aktiengesellschaft | 30.07B |